As proven, men treated with pygeum bark were twice as
likely than the placebo group to report symptom and improvement.
Not exact matches
Instead, they found that the
group of participants who received Infliximab were less
likely to recover from depression
than those who got the
placebo.
For example, people who were taking only an inactive
placebo were more
likely than patients in other
groups to drop out of study, suggesting these families had noticed the
placebo «medication» wasn't working.
Participants receiving supplements were 26.3 % (95 % CI 8.3 % to 44 %) less
likely to be reported for antisocial behaviour
than those who received
placebo (mean difference 11.8 less infringements in the supplement
group, p = 0.03).